Preliminary report an gemcitabine (G) - Ifosfamide (I) - Cisplatin (P) phase I/II trial in patients with advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Bourgeois, H [1 ]
Lemerre, D [1 ]
Chicoyneau, V [1 ]
Paitry, T [1 ]
Chleze, S [1 ]
Fruge, F [1 ]
Boita, F [1 ]
Meurice, JC [1 ]
Daban, A [1 ]
机构：
[1] Reg Univ Hosp Miletrie, F-86021 Poitiers, France
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81462-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1042
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [1] Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: A preliminary report
    Shepherd, FA
    Burkes, R
    Cormier, Y
    Crump, M
    Feld, R
    Strack, T
    LUNG CANCER, 1996, 14 (01) : 135 - 144
  • [2] Phase II study of Gemcitabine, ifosfamide and cisplatin (GIP) in patients with advanced non-small cell lung cancer (NSCLC)
    De las Penas, R
    Busquier, I
    Munarriz, J
    Lopez, A
    Llorente, R
    Alberola, V
    Frau, A
    ANNALS OF ONCOLOGY, 1998, 9 : 88 - 88
  • [3] Gemcitabine (G), ifosfamide (I), vinorelbine (N) in advanced non-small cell lung cancer (NSCLC):: A phase II study.
    Morère, JF
    Pailler, MC
    Saintigny, P
    Bréchot, JM
    Morin, F
    Mir, D
    Martinez, A
    Breau, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 705S - 705S
  • [4] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Valerie Israel
    Scott T. Tagawa
    Terry Snyder
    Susan Jeffers
    Derek Raghavan
    Investigational New Drugs, 2004, 22 : 291 - 297
  • [5] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Israel, V
    Tagawa, ST
    Snyder, T
    Jeffers, S
    Raghavan, D
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (03) : 291 - 297
  • [6] A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer
    Kunitoh, H
    Akiyama, Y
    Kusaba, H
    Yamamoto, N
    Sekine, I
    Ohe, Y
    Kubota, K
    Tamura, T
    Shinkai, T
    Kodama, T
    Goto, K
    Niho, S
    Nishiwaki, Y
    Saijo, N
    LUNG CANCER, 2001, 33 (2-3) : 259 - 265
  • [7] A phase II trial of the combination of gemcitabine, ifosfamide and cisplatin in the treatment of advanced non-small cell lung cancer
    Vadell-Nadal, C
    Nogué-Aliguer, M
    Fabregat-Mayol, X
    Saigí-Grau, E
    Gallén-Castillo, M
    LUNG CANCER, 2000, 28 (02) : 109 - 115
  • [8] Phase I/II trial of gemcitabine (G) administered every other week plus cisplatin (P) in advanced non-small cell lung cancer (NSCLC): final results
    Nelli, F
    De Marinis, F
    Ariganello, O
    Belli, R
    Cipri, A
    Diana, F
    Lampignano, M
    Paoluzzi, L
    Martelli, O
    Migliorino, MR
    Di Molfetta, M
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 410 - 411
  • [9] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
  • [10] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
    Pirker, R
    Krajnik, G
    MohnStaudner, A
    Marhold, F
    Malayeri, R
    Zochbauer, S
    Kummer, F
    Greil, R
    Huber, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1139 - 1139
12345